Notices

• Medicare Program; Town Hall Meeting on the FY 2022 Applications for New Medical Services and Technologies Add-On Payments

  

• Medicare Program; Approval of Application by The Compliance Team for Initial CMS-Approval of its Home Infusion Therapy Accreditation Program; Correction

  

• Medicare Program; Approval of Application by National Association of Boards of Pharmacy for Initial CMS-Approval of Its Home Infusion Therapy Accreditation Program

  

• Medicare and Medicaid Programs; Quarterly Listing of Program Issuances-April Through June 2020

  

• Medicare Program; Announcement of the Advisory Panel on Hospital Outpatient Payment Meeting

  

• Medicare and Medicaid Programs; Application From DNV GL Healthcare USA Inc. for Initial CMS Approval of Its Psychiatric Hospital Accreditation Program

  

• Medicare Program; Administrative Law Judge Hearing Program for Medicare Claim and Entitlement Appeals; Quarterly Listing of Program Issuances-October 2019 Through March 2020

  

• Medicare and Medicaid Programs; Application From the Joint Commission for Continued Approval of its Hospital Accreditation Program

  

• Medicare Program; Virtual Meeting of the Medicare Evidence Development and Coverage Advisory Committee-July 22, 2020

  

• Announcement of the Advisory Panel on Outreach and Education (APOE) June 25, 2020 Meeting

  

• Medicare and Medicaid Programs; Application From the Joint Commission (TJC) for Continued Approval of its Home Health Agency Accreditation Program; Correction

  

• Medicare and Medicaid Programs; Application From The Joint Commission (TJC) for Continued CMS-Approval of Its Ambulatory Surgical Center (ASC) Accreditation Program

  

• Announcement of the Re-Approval of AABB (Formerly Known as the American Association of Blood Banks) as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments of 1988

  

• Medicare and Medicaid Programs: Application From DNV-GL Healthcare USA, Inc. for Continued Approval of its Critical Access Hospital Accreditation Program

  

• Medicare Program; Public Meeting on June 22, 2020 Regarding New and Reconsidered Clinical Diagnostic Laboratory Test Codes for the Clinical Laboratory Fee Schedule for Calendar Year 2021

  

• Medicare Program; Application From The Compliance Team for Initial CMS Approval of its Home Infusion Therapy Accreditation Program

  

• Medicare Program; Application From National Association of Boards of Pharmacy for Initial CMS-Approval of Its Home Infusion Therapy Accreditation Program

  

• Medicare Program; Application From Community Health Accreditation Partner (CHAP) for Initial CMS-Approval of Its Home Infusion Therapy Accreditation Program

  

• Medicare Program; Approval of Application by the Accreditation Commission for Healthcare for Initial CMS-Approval of Its Home Infusion Therapy Accreditation Program

  

• Medicare and Medicaid Programs; Quarterly Listing of Program Issuances-January Through March 2020